Body Mass Index and Retinopathy in Type 1 Diabetic Patients

Table 2

Metabolic and clinical parameters of type 1 diabetic patients (𝑛=176) divided into three groups according to diabetic retinopathy status.

	Group 1; (𝑛=86)	Group 2; (𝑛=33)	Group 3; (𝑛=57)	𝑃
HbA1c (%)*	7.25±1.56	7.47±1.44	8.56±1.32	<0.01
Total cholesterol (mmol/L)*	4.74±1.08	5.18±1.01	5.48±1.17	<0.01
Triglycerides (mmol/L)*	1.42±0.77	1.41±0.81	1.66±0.80	ns
HDL-cholesterol (mmol/L)*	1.28±0.41	1.35±0.36	1.28±0.38	ns
Insulin dosage (IU/kg)*	0.71±0.21	0.77±0.16	0.72±0.17	ns
Systolic blood pressure (mmHg)*	127.21±13.89	135.76±20.75	136.40±20.62	<0.01
Diastolic blood pressure (mmHg)*	79.77±10.06	81.82±9.03	84.65±11.66	<0.05
Antihypertensive treatment**	32.56	60.61	57.89	<0.01
Hypolipidemic treatment**	25.58	39.39	54.39	<0.01
Nephropathy**	5.81	24.24	78.95	<0.01

∗mean ± SD ∗∗%; percentage.
Group 1: no retinopathy, group 2: mild/moderate nonproliferative diabetic retinopathy; group 3: severe/very severe nonproliferative diabetic retinopathy or proliferative diabetic retinopathy; HbA₁c: glycated hemoglobin value; nephropathy: patients with type 1 diabetes on hemodialysis due to diabetic nephropathy.